Wang W-W, Cao R, Rao Z-R, Chen L-W
Institute of Neurosciences, The Fourth Military Medical University, Xi'an, 710032, PR China.
Brain Res. 2004 Feb 20;998(2):174-83. doi: 10.1016/j.brainres.2003.11.034.
Dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein, 32 kDa (DARPP-32) is a key element of dopamine/D1/DARPP-32/protein phosphatase-1 (PP-1) signaling cascades of mammalian brain. We are interested in the expression patterns of N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors in DARPP-32-containing neurons, which may constitute morphological basis for interaction between dopamine and ionotropic glutamate receptors in dopaminoceptive cells. Double immunofluorescence was performed to visualize neurons showing coexpression of DARPP-32 with NMDA or AMPA receptor subunits (i.e., NR1, NR2a/b, glutamate receptor subunit 1 [GluR1], GluR2/3, and GluR4) in the forebrains of rats. Distribution of DARPP-32-positive neurons completely or partially overlapped with that of NMDA receptor- or AMPA receptor-immunoreactive ones in the frontal and parietal cortex, hippocampus and neostriatum, and neurons double-labeled with DARPP-32/NR1, DARPP-32/NR2a/b, DARPP-32/GluR1, DARPP-32/GluR2/3, or DARPP-32/GluR4 immunoreactivity were numerously observed. Semiquantification analysis indicated that most of DARPP-32-containing neurons (86-98%) expressed NR1, NR2a/b and GluR2/3, while less of them (14-90%) expressed GluR1 and GluR4. Although high rates (90-98%) of DARPP-32-positive cells expressed NMDA receptors in all regions above, variant percentages of them expressing AMPA receptor subunits were observed among the cortex (54-90%), hippocampus (59-97%) and neostriatum (14-97%). The study presents differential expression patterns of NMDA and AMPA receptors in DARPP-32-postive neurons in these forebrain regions. Taken together with previous reports, the present data suggest that interaction between dopamine and glutamate receptors may occur in the dopaminoceptive neurons with distinct receptor compositions and may be involved in modulating neuronal properties and excitotoxicity in mammalian forebrain.
多巴胺与32 kDa环磷腺苷调节磷蛋白(DARPP - 32)是哺乳动物脑内多巴胺/D1/DARPP - 32/蛋白磷酸酶-1(PP - 1)信号级联反应的关键元件。我们感兴趣的是含DARPP - 32神经元中N - 甲基 - D - 天冬氨酸(NMDA)和α - 氨基 - 3 - 羟基 - 5 - 甲基 - 4 - 异恶唑丙酸(AMPA)受体的表达模式,这可能构成多巴胺能感受细胞中多巴胺与离子型谷氨酸受体相互作用的形态学基础。运用双重免疫荧光法观察大鼠前脑内同时表达DARPP - 32与NMDA或AMPA受体亚基(即NR1、NR2a/b、谷氨酸受体亚基1 [GluR1]、GluR2/3和GluR4)的神经元。在额叶和顶叶皮质、海马及新纹状体中,DARPP - 32阳性神经元的分布与NMDA受体或AMPA受体免疫反应阳性神经元的分布完全或部分重叠,并且大量观察到同时被DARPP - 32/NR1、DARPP - 32/NR2a/b、DARPP - 32/GluR1、DARPP - 32/GluR2/3或DARPP - 32/GluR4免疫标记的神经元。半定量分析表明,大多数含DARPP - 32的神经元(86% - 98%)表达NR1、NR2a/b和GluR2/3,而较少比例的神经元(14% - 90%)表达GluR1和GluR4。尽管上述所有区域中90% - 98%的DARPP - 32阳性细胞表达NMDA受体,但在皮质(54% - 90%)、海马(59% - 97%)和新纹状体(14% - 97%)中观察到表达AMPA受体亚基的细胞比例存在差异。该研究展示了这些前脑区域中DARPP - 32阳性神经元内NMDA和AMPA受体的差异表达模式。结合先前的报道,目前的数据表明多巴胺与谷氨酸受体之间的相互作用可能发生在具有不同受体组成的多巴胺能感受神经元中,并可能参与调节哺乳动物前脑的神经元特性和兴奋性毒性。